New Members Should Upload Their Top Stocks Now for Our Expert Analysis
To all the new Coalition members who've recently joined our ranks, we'd like to officially welcome you aboard and get you up to speed on our interactive portfolio guidance features. A primary goal of ours is to help you to automatically avoid the number one mistake...
Friday, December 6, 2013 by Charlie Buck
LIFS Continues Business Expansion; Expect More Share-Price Volatility
Life Stem Genetics (LIFS) is an early-stage growth stock, and we are not surprised by the recent volatility in both share-price and trading volume.
Friday, November 22, 2013 by Scott Fraser
Life Stem Genetics (LIFS) is Surging Higher Following Our Initial Buy Signal
We initiated our strategic buy-coverage of Life Stem Genetics (LIFS) in late-October of this year right around the $1.05 per share level...
Friday, November 15, 2013 by Charlie Buck
Our advanced Life Science Wealth Evolution is reflected in our new report and recommendation on Life Stem Genetics (LIFS)
Life Stem Genetics has emerged as a high-value-potential stock situation in the Adult Stem Cell Therapy sector. You can view our 16-page print report on LIFS by clicking the Stock Profit Guide tab above...
Sunday, October 27, 2013 by Scott Fraser
If you bought too high during the spike in SNPK, there may be a 2nd profit opportunity brewing
Recent surveys reflect a number of our new members who must have bought SNPK shares, back when it was Sunpeaks Ventures, during its spike in the spring of 2012. Although this stock has long since crashed and now trades under the symbol PHRX as Pharmagen...
Friday, October 11, 2013 by Charlie Buck
Our Full Dossier on Uranerz Energy (URZ) to be delivered via Courier
Last month, we updated you on Uranerz Energy's progress at the Nichols Ranch Uranium Project, Wyoming. To recap, the company has completed drilling of the first of two deep disposal wells...
Wednesday, August 21, 2013 by Charlie Buck